Voxel-based morphometry in the assessment of brain condition in patients after breast cancer treatment (Part 2)

Background. Breast cancer is one of the most common malignancies in women. Modern treatment methods, such as chemotherapy, can cause adverse effects on the central nervous system, including cognitive impairment known as “chemobrain”. Brain imaging techniques, such as voxel-based morphometry (VBM), are essential for diagnosing these changes. Objective. The study aimed to assess changes in brain structure volumes in breast cancer survivors using voxel-based morphometry. Design and Methods. The study included 86 patients (mean age 43.27 ± 4.38 years) who underwent breast cancer treatment and 26 healthy volunteers (mean age 44 ± 5.68 years). MRI of the brain was performed using the MPRAGE sequence to exclude organic pathology and analyze brain structure volumes. Data analysis was conducted using the VolBrain platform. Results. Morphometric analysis revealed a statistically significant reduction in gray and white matter volumes in breast cancer patients after chemotherapy compared to the control group. This reduction was accompanied by complaints of cognitive decline, including memory and attention deficits, which correlated with decreased brain structure volumes. Conclusion. Voxel-based morphometry enables the detection of subtle changes in brain structure in breast cancer survivors. The results confirm the significant impact of chemotherapy on the central nervous system and highlight the need for early diagnosis and rehabilitation of cognitive impairments.

1. Bukkieva T, Pospelova M, Efimtsev A, et al. Microstructural Properties of Brain White Matter Tracts in Breast Cancer Survivors: A Diffusion Tensor Imaging Study. Pathophysiology [Internet]. 2022 Dec 1 [cited 2024 Apr 10];29(4):595–609. Available from: https://pubmed.ncbi.nlm.nih.gov/36278563/

2. Nikolaeva A, Pospelova M, Krasnikova V, et al. Elevated Levels of Serum Biomarkers Associated with Damage to the CNS Neurons and Endothelial Cells Are Linked with Changes in Brain Connectivity in Breast Cancer Patients with Vestibulo-Atactic Syndrome. Pathophysiology 2023, Vol 30, Pages 260–274 [Internet]. 2023 Jun 15 [cited 2024 Apr 10];30(2):260–74. Available from: https://www.mdpi.com/1873-149X/30/2/22/htm

3. Manjón JV, Coupé P. volBrain: An Online MRI Brain Volumetry System. Front Neuroinform [Internet]. 2016 Jul 27 [cited 2024 Aug 13];10(JUL). Available from: https://pubmed.ncbi.nlm.nih.gov/27512372/

4. Banker L, Tadi P. Neuroanatomy, Precentral Gyrus. StatPearls [Internet]. 2023 Jul 24 [cited 2024 Aug 13]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK544218/

5. Silva AB, Liu JR, Zhao L, et al. A Neurosurgical Functional Dissection of the Middle Precentral Gyrus during Speech Production. J Neurosci [Internet]. 2022 Nov 9 [cited 2024 Aug 13];42(45):8416–26. Available from: https://pubmed.ncbi.nlm.nih.gov/36351829/

6. El-Baba RM, Schury MP. Neuroanatomy, Frontal Cortex. StatPearls [Internet]. 2023 May 29 [cited 2024 Aug 13]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554483/

7. Jimsheleishvili S, Dididze M. Neuroanatomy, Cerebellum. StatPearls [Internet]. 2023 Jul 24 [cited 2024 Aug 13]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK538167/

8. Guell X, Schmahmann JD, Gabrieli JDE, Ghosh SS. Functional gradients of the cerebellum. Elife. 2018 Aug 14;7.

9. Sankey EW, Srinivasan ES, Mehta VA, et al. Perioperative Assessment of Cerebellar Masses and the Potential for Cerebellar Cognitive Affective Syndrome. World Neurosurg. 2020 Dec 1;144:222–30.

10. Hassan H, Ehsanula H, Pattanshetti M. Stroke of the inferiomedial temporal lobe causing word agnosia. Case Reports [Internet]. 2017 Jul 26 [cited 2024 Aug 13];2017:bcr-2015-214184. Available from: https://casereports.bmj.com/content/2017/bcr-2015-214184

11. Carretero RG, Beamonte-Vela BN, Silvano-Cocinero JD, Alvarez-Mendez A. Behavioural changes as the first manifestation of a silent frontal lobe stroke. BMJ Case Reports CP [Internet]. 2019 Jan 1 [cited 2024 Aug 13];12(1):bcr-2018-227617. Available from: https://casereports.bmj.com/content/12/1/bcr-2018-227617

12. Daniel E, Deng F, Patel SK, et al. Altered gyrification in chemotherapy-treated older long-term breast cancer survivors. Res Sq [Internet]. 2023 Apr 10 [cited 2024 Aug 13]; Available from: https://pmc/articles/PMC10120747/

13. Inagaki M, Yoshikawa E, Matsuoka Y, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer [Internet]. 2007 Jan 1 [cited 2024 Aug 13];109(1):146–56. Available from: https://pubmed.ncbi.nlm.nih.gov/17131349/

14. McDonald BC, Conroy SK, Ahles TA, et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat [Internet]. 2010 Oct [cited 2024 Aug 13];123(3):819–28. Available from: https://pubmed.ncbi.nlm.nih.gov/20690040/